M1 AChR
Showing 1 - 25 of >10,000
Multiple Sclerosis Trial in London (PIPE-307)
Completed
- Multiple Sclerosis
-
London, United KingdomHammersmith Medicines Research
Oct 4, 2022
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)
Not yet recruiting
- Myasthenia Gravis
- +3 more
- CNP-106
- Placebo
-
Chicago, IllinoisResearch Site
Oct 30, 2023
Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1
Recruiting
- Schizophrenia
- +2 more
- 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 16, 2022
Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)
Not yet recruiting
- Healthy Women of Child Bearing Potential
- R21/Matrix-M1
- +2 more
- (no location specified)
Oct 10, 2023
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Healthy Young Adults Trial in Serdang (TMS, Sham)
Recruiting
- Healthy Young Adults
- TMS
- Sham
-
Serdang, Selangor, MalaysiaHospital Sultan Abdul Aziz Shah
Sep 14, 2023
User Experience of the OSR M-1
Suspended
- Covid19
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Nov 15, 2022
Type 1 Diabetes Trial in Mainz, Neuss (M1 Pram P037, Insulin lispro)
Completed
- Type 1 Diabetes Mellitus
- M1 Pram P037
- Insulin lispro
-
Mainz, Germany
- +1 more
Jun 23, 2022
Malaria, Vivax Trial in Oxford (Pvs25-IMX313/Matrix-M1)
Recruiting
- Malaria, Vivax
- Pvs25-IMX313/Matrix-M1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Mar 7, 2022
The Specificity, Sensitivity and Clinical Correlation of CBA,
Completed
- Detection Autoantibody of Myasthenia Gravis
- CBA Assay
-
Beijing, China
- +1 more
Jan 17, 2023
Malaria, Vivax Trial in Oxford (PvDBPII/Matrix-M1)
Recruiting
- Malaria, Vivax
- PvDBPII/Matrix-M1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Feb 8, 2022
Immune-Mediated Inflammatory Disease Trial in Kópavogur (SK-M11/3A1 Digital health program)
Not yet recruiting
- Immune-Mediated Inflammatory Disease
- SK-M11/3A1 Digital health program
-
Kópavogur, IcelandHúðlæknastöðin dermatology clinic
Oct 26, 2023
Solid Tumors, Adult Trial in Dallas, Hangzhou (HF158K1 /Arm 2 mg/m², HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m²)
Not yet recruiting
- Solid Tumors, Adult
- HF158K1 /Arm 2 mg/m²
- +5 more
-
Dallas, Texas
- +2 more
May 6, 2023
Gynecological Malignancies Trial in Beijing (BL-M07D1)
Not yet recruiting
- Gynecological Malignancies
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Nov 15, 2023
pcTBS, Pain Trial in Hangzhou (pcTBS of M1, SHAM stimulation)
Not yet recruiting
- pcTBS
- Pain
- pcTBS of M1
- SHAM stimulation
-
Hangzhou, ChinaThe second affiliated hospital of Zhejiang University hangzhou
May 2, 2023
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)
Not yet recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 28, 2023
Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)
Not yet recruiting
- Chronic Pain
- +2 more
- Vitamin C
- Placebo
-
Toronto, Ontario, Canada
- +2 more
Nov 7, 2023
NSCLC Trial in Guangzhou (BL-M07D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 1, 2023
Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))
Suspended
- Infection
- Fecal Microbiota Transplantation (FMT)
-
Brampton, Ontario, Canada
- +12 more
Nov 1, 2022
Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)
Not yet recruiting
- Her2-positive/Low-expression Urinary and Digestive Tract Tumors
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023
NSCLC Trial in Shanghai (BL-M02D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 10, 2023